A framework for decisions about research with HPAI H5N1 viruses

Science

Volumn 339, Issue 6123, 2013, Pages 1036-1037

  Patterson, Amy P ^a   Tabak, Lawrence A ^a   Fauci, Anthony S ^a   Collins, Francis S ^a   Howard, Sally ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AVIAN INFLUENZA; DECISION MAKING; HEALTH POLICY; HEALTH SERVICES; INVESTMENT; PATHOGEN; RESEARCH;

AVIAN INFLUENZA VIRUS; CONCEPTUAL FRAMEWORK; INFLUENZA VIRUS A H5N1; MEDICAL RESEARCH; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; ANIMAL; ARTICLE; AVIAN INFLUENZA; BIRD; DISEASE TRANSMISSION; EDUCATION; GENETICS; HUMAN; INFLUENZA; PATHOGENICITY; PRACTICE GUIDELINE; SAFETY;

AVES;

ANIMALS; BIOMEDICAL RESEARCH; BIRDS; GUIDELINES AS TOPIC; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA, HUMAN; SAFETY;

MLCS; MLOWN;

EID: 84874382407     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1236194     Document Type: Short Survey

References (14)

1. Food and Agriculture Organization, H5N1 Highly Pathogenic Avian Influenza - Global Overview (FAO, Rome, 2012); www.fao.org/docrep/015/an388e/an388e.pdf.
2. Centers for Disease Control and Prevention, Highly Pathogenic Avian Influenza A (H5N1) in People; www.cdc.gov/flu/avianflu/h5n1-people.htm.
3. S. Herfst et al., Science 336, 1534 (2012).
4. M. Imai et al., Nature 486, 420 (2012).
5. R. A. M. Fouchier, A. García-Sastre, Y. Kawaoka, Nature 481, 443 (2012).
6. R. A. M. Fouchier et al., Science 335, 400 (2012).
7. R. A. M. Fouchier, A. García-Sastre, Y. Kawaoka, Nature 493, 609 (2013).
8. HHS, www.hhs.gov/.
9. Gain-of-Function Research on Highly Pathogenic Avian Influenza H5N1 Viruses: An International Consultative Workshop, Bethesda, Maryland, 17 to 18 December 2012; http://oba.od.nih.gov/biosecurity/internationalwebcast. html#Dec2012.
10. Office of Biotechnology Activities, NIH, U.S. Government Policy for Oversight of Life Sciences Dual Use Research of Concern, 29 March 2012; www.phe.gov/s3/dualuse/Documents/us-policy-durc-032812.pdf.
11. Report of the Trans-Federal Task Force on Optimizing Biosafety and Biocontainment Oversight (HHS, Washington, DC, 2009), pp. 40-67; www.phe.gov/Preparedness/legal/boards/biosafetytaskforce/Documents/ transfedbiocontainmentrpt092009.pdf.
12. Centers for Disease Control and Prevention (CDC) HHS, Fed. Regist. 77(201), 63783 (2012).
13. RAC meetings, http://oba.od.nih.gov/rdna-rac/rac-past-meetings-2010.html
14. NIH Guidelines for Research Involving Recombinant DNA Molecules (NIH, HHS, Washington, DC, 2013), http://oba.od.nih.gov/rdna/nih-guidelines-oba.html